Pfizer Inc. is committed to advancing its information technology (IT) capabilities, which have been evolving to encompass the coordination of the firm’s assets and internal processes as well as their interfirm transactions and relationships. The company emphasizes the importance of mobilizing and deploying IT-based resources in combination with leveraging the value of other resources and capabilities to support and enhance business strategies and work processes. Pfizer’s IT capability is critical in transforming the firm into a competitive force, as it represents the application of both physical and intangible IT resources, including technology, knowledge, practices, and management skills, to further organizational goals. The company’s business strategy focuses on advancing its product pipeline and maximizing the value of existing products through strategic business development activities, which are seen as enablers of its strategies. Pfizer continually seeks to expand its product portfolio by prioritizing development and acquisitions targeted at critical unmet patient needs, which requires effective management of its IT resources to ensure operational efficiency and market responsiveness. The firm’s R&D operations are integral to executing its business strategy, and investments in R&D and strategic initiatives are expected to support both near- and long-term growth plans. The restructuring program initiated in 2019 aims to align the cost base and support model with the operating structure, enhancing operational flexibility and efficiency. Furthermore, Pfizer’s commitment to innovation and the integration of advanced science and technologies into its operations underscores the role of IT in driving breakthroughs that change patients' lives. The company’s ability to provide data and information with appropriate levels of accuracy, timeliness, reliability, and security is essential for meeting changing business needs and directions. As part of its operational strategy, Pfizer is focused on optimizing its end-to-end R&D operations to reduce costs and cycle times while prioritizing its internal R&D portfolio in areas where its capabilities are differentiated. The firm also recognizes the need for effective information management and data analytics to support decision-making processes and enhance performance outcomes. The impact of external influences, including regulatory pressures and market dynamics, necessitates a robust IT governance framework to manage risks and ensure compliance. Overall, Pfizer’s strategic resource allocation reflects its commitment to leveraging IT capabilities to drive business transformation, enhance organizational effectiveness, and create long-term value for stakeholders.